首页> 外文期刊>Monatshefte fur Chemie >Synthesis and in vitro evaluation of novel N-cycloalkylcarbamates as potential cholinesterase inhibitors
【24h】

Synthesis and in vitro evaluation of novel N-cycloalkylcarbamates as potential cholinesterase inhibitors

机译:新型N-环烷基氨基酯作为潜在的胆碱酯酶抑制剂的合成和体外评价

获取原文
获取原文并翻译 | 示例
       

摘要

This present paper describes the preparation and characterization of a series of O-substituted N-cycloalkylcarbamate derivatives. These compounds were tested as inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). All studied carbamates exhibited moderate inhibitory activity of both cholinesterases with values of IC50 in the range of 36.1-78.6 mu M for AChE and 9.8-215.4 mu M for BChE, respectively. These values are comparable with those values of inhibition obtained with the established drug rivastigmine. The cytotoxicity of all carbamates was evaluated using standard in vitro test with Jurkat cells. Many of the studied carbamates can be considered as promising compounds for potential medicinal applications with regard to their inhibitory activity as well as negligible cytotoxicity.
机译:本文介绍了一系列O-取代的N-环烷基氨基甲酸酯衍生物的制备和表征。 将这些化合物作为乙酰胆碱酯酶(ACHE)和丁酰胆碱酯酶(BCHE)的抑制剂进行测试。 所有研究的氨基甲酸酯都表现出胆碱酯酶的适度抑制活性,IC 50的值分别为36.1-78.6μm,分别用于BCHE的9.8-215.4μm。 这些值与用已建立的药物牛瘟获得的抑制值相当。 使用标准用Jurkat细胞进行评估所有氨基甲酸酯的细胞毒性。 许多研究的氨基甲酸酯可以被认为是具有潜在药用应用的有希望的化合物,其抑制活性以及可忽略的细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号